Search Results

There are 15760 results for: content related to: Placebo influences on dyskinesia in Parkinson's disease

  1. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD000208

  2. Cholinergic medication for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Irina Tammenmaa, John McGrath, Eila ES Sailas and Karla Soares-Weiser

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD000207

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Article first published online : 9 SEP 2008, DOI: 10.1002/mds.22022

  5. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Article first published online : 12 NOV 2008, DOI: 10.1002/mds.22208

  6. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23072

  7. Calcium channel blockers for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Adib Essali, Hany Deirawan, Karla Soares-Weiser and Clive E Adams

    Published Online : 9 NOV 2011, DOI: 10.1002/14651858.CD000206.pub3

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  9. Benzodiazepines for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Paranthaman Sethupathi Bhoopathi and Karla Soares-Weiser

    Published Online : 19 JUL 2006, DOI: 10.1002/14651858.CD000205.pub2

  10. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Article first published online : 16 JUL 2001, DOI: 10.1002/mds.1148

  11. Levodopa-induced dyskinesias

    Movement Disorders

    Volume 22, Issue 10, 30 July 2007, Pages: 1379–1389, Giovanni Fabbrini, Jonathan M. Brotchie, Francisco Grandas, Masahiro Nomoto and Christopher G. Goetz

    Article first published online : 11 APR 2007, DOI: 10.1002/mds.21475

  12. Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial

    Movement Disorders

    Volume 22, Issue 2, 15 January 2007, Pages: 179–186, Christopher G. Goetz, Philippe Damier, Christine Hicking, Eugene Laska, Thomas Müller, C. Warren Olanow, Olivier Rascol and Hermann Russ

    Article first published online : 8 NOV 2006, DOI: 10.1002/mds.21226

  13. Parkinson's disease home diary: Further validation and implications for clinical trials

    Movement Disorders

    Volume 19, Issue 12, December 2004, Pages: 1409–1413, Robert A. Hauser, Frieda Deckers and Philippe Lehert

    Article first published online : 21 JUL 2004, DOI: 10.1002/mds.20248

  14. Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

    European Journal of Neuroscience

    Volume 37, Issue 5, March 2013, Pages: 831–838, Philippe Huot, Tom H. Johnston, Tessa Snoeren, James B. Koprich, Michael P. Hill, Susan H. Fox and Jonathan M. Brotchie

    Article first published online : 3 JAN 2013, DOI: 10.1111/ejn.12093

  15. Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials

    European Journal of Neurology

    Volume 21, Issue 3, March 2014, Pages: 433–440, M. Chondrogiorgi, A. Tatsioni, H. Reichmann and S. Konitsiotis

    Article first published online : 7 DEC 2013, DOI: 10.1111/ene.12318

  16. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  17. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Article first published online : 27 JUL 2006, DOI: 10.1002/mds.20936

  18. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Article first published online : 27 JAN 2010, DOI: 10.1002/mds.22960

  19. Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2059–2066, Louisa Clare Johnston, Michael John Jackson, Sarah Rose, Andrew Christopher McCreary and Peter Jenner

    Article first published online : 18 AUG 2010, DOI: 10.1002/mds.23249

  20. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1064–1071, C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi and for the Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Article first published online : 29 APR 2013, DOI: 10.1002/mds.25364